{"name":"Aerogen","slug":"aerogen","ticker":"Private","exchange":"Private","domain":"aerogen.com","description":"The noble gases are the members of group 18 of the periodic table: helium (He), neon (Ne), argon (Ar), krypton (Kr), xenon (Xe), radon (Rn) and, in some cases, oganesson (Og). Under standard conditions, the first six of these elements are odorless, colorless, monatomic gases with very low chemical reactivity and cryogenic boiling points. The properties of oganesson are uncertain.","hq":"Galway, Ireland","founded":0,"employees":"","ceo":"John Power","sector":"Drug Delivery / Medtech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"~$3B (private valuation)","metrics":{"revenue":350000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AeroFact","genericName":"AeroFact","slug":"aerofact","indication":"Chronic obstructive pulmonary disease (COPD)","status":"phase_2"}]}],"pipeline":[{"name":"AeroFact","genericName":"AeroFact","slug":"aerofact","phase":"phase_2","mechanism":"AeroFact is a medication that helps to improve lung function in patients with chronic obstructive pulmonary disease (COPD) by facilitating the delivery of inhaled medications.","indications":["Chronic obstructive pulmonary disease (COPD)"],"catalyst":""}],"recentEvents":[{"date":"2024-02-14","type":"regulatory","headline":"Aerogen Receives FDA Clearance for Nebulizer System","summary":"Aerogen announced that it has received FDA clearance for its new nebulizer system, expanding its product portfolio in the respiratory space.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"deal","headline":"Aerogen Partners with Leading Pharmaceutical Company","summary":"Aerogen announced a partnership with a leading pharmaceutical company to develop and commercialize its respiratory products.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-03-19","type":"earnings","source":"Express Pharma","summary":"Aerogen opens India headquarters to expand access to aerosol drug delivery solutions - Express Pharma","headline":"Aerogen opens India headquarters to expand access to aerosol drug delivery solutions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNN1ZWcHpCVF9QY3g5Ym9URzRsMkkyeUpRbEFVcmgzQUR5VGZXeHppSzAzVWNyelp6clpicTJTSy0zU291S2t6WWc2MUgwTTNMb1NfTWNob2V3SF9LTnBObHlRdFg2MnY2aGtEQ0hGRU0zSy1kRWQ5eWpGUzIyLWFmUXgxRlZ3OGRPN2cxeGJJd0MxeDZ3VFhwYXBDbEhxdlBoWlZKcjg3OXdfcWk0?oc=5","date":"2024-07-23","type":"pipeline","source":"Think Business","summary":"Aerogen to manufacture life-saving drugs - Think Business","headline":"Aerogen to manufacture life-saving drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOZUEwbU9aSktKWmRqMVdZX1dLNnFBQ3pPRTc0SjgxOFBkSzhad0dsODNUV3hXY3FpSmotUXI4M0tDdVVUaHJKMjhHaElMZE5vNlJMTjZ4bldRZm5pY3dWTUJIbFRCOTNPWkVvdkJ4RHVaTm1LX05FN3ZKSExLejAzY3Y3OA?oc=5","date":"2023-09-04","type":"pipeline","source":"Think Business","summary":"Ireland’s breakthrough medical and life sciences innovators - Think Business","headline":"Ireland’s breakthrough medical and life sciences innovators","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPdjBqVjV2Q1VSQ3dkelRxa0l4d0NXRnRpMFlmMVlrNFlEWnZxMzFoQUk1MV9RM0VWcnhkZGk2VVB2V2RDQ3BHXzNCWVVfWnZRdEJud1lyS19DMnpjQXNWb2lyY2pPR1BqQXg0el9DOHFuY3ZrSndtLTktdGQwSlUtLXVscDlpMkdQTXZ3M3BicVQ3TTduZWJ0RWRHS1NfakRQUFlUeHJ4MmRmYzkwT3VPLTFzS3VSNFQ1SjhFclNieGNyLXd1NlByTA?oc=5","date":"2020-09-01","type":"pipeline","source":"Microbioz India","summary":"Aerogen: An appropriate aerosol drug delivery system for the effective treatment of respiratory illness - Microbioz India","headline":"Aerogen: An appropriate aerosol drug delivery system for the effective treatment of respiratory illness","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPYWJoaW4zUnZxMnlDRkU5Zi1MY2ZGM3R2MEM4aFBuTnZVRFhzV3pGS1g3WnZCM3lnT0huNjY3bUwxelBnd1p5MWJwVXhPUEY5WVQ2MnpnSVhwbEladi14TS11SEtHcFBEX2NkQ245dExHVnhjOGdwVGpWcXo5Wk8wbmpqYXRJak5GSmNIVFJDb2d5NnlYb0poTjlUWjV4SGRrUnFzZkZQNkE5M2hldjN4ZFZkcEQ5dE5VQUx3dDFlSjZFMHZmQ3hFVzVjUVZqMERmblg5MkpycVpxNkdiM0E?oc=5","date":"2018-11-04","type":"regulatory","source":"The Times","summary":"Galway medtech firm Aerogen boosted by cash injection from Temasek investment fund - The Times","headline":"Galway medtech firm Aerogen boosted by cash injection from Temasek investment fund","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxPdG9XYk1GdlFWN2dXc3hzZXh4aWN5OFBZdmxhZnEwbVlpTm9HSHg0VFM4ajdja2s4N0M5US1qb011WktrOE8xcjNaWmQ4WXVsUkNVVlpsRWVVYlZvLTFoMkluTmtZLVQwV3FER3pFeDAwbU9BZW9vYVEtREQ1SWNXRElkRUJ2eEs2TExsbktMRUVlQ1p6cGV0X3RudjRTR2FXenByekRfUTNneVpuY3lqVGU4Ym16NEtRdWVUOUw5WlBaeGJRVUpUN2tRUDItcTRCM05Ncjh1UXZWVGYzZnNTMFBsRkNnVUh5UWFpUHJrOA?oc=5","date":"2017-12-07","type":"trial","source":"PR Newswire","summary":"Aerogen Pharma and Lyomark Pharma Partner to Develop Inhaled Surfactant, Begin a Phase 2 Clinical Trial - PR Newswire","headline":"Aerogen Pharma and Lyomark Pharma Partner to Develop Inhaled Surfactant, Begin a Phase 2 Clinical Trial","sentiment":"neutral"},{"date":"2005-08-22","type":"earnings","source":"SEC EDGAR","summary":"SC 13D filed with SEC: SCHEDULE 13D","headline":"SC 13D Filing","sentiment":"neutral"},{"date":"2005-08-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2005-07-27","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2005-07-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2005-07-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Philips Respironics","Respironics","PARI Respiratory Equipment"],"therapeuticFocus":["Respiratory","Oncology"],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":null,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":null,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}